Texte intégral
United States Court of Appeals
for the Federal Circuit
______________________
August 16, 2011
ERRATUM
______________________
Appeal No. 2010-1102,-1103
IN RE BRIMONIDINE PATENT LITIGATION
----------------------------------------------
ALLERGAN, INC.,
v.
EXELA PHARMSCI INC. and EXELA PHARMSCI
PVT., LTD.,
and
APOTEX INC. and APOTEX CORP.,
Decided: May 19, 2011
Precedential Opinion
______________________
Please make the following change:
Page 11, footnote 1, lines 9-10, the text should be
changed to read
Dose Response Study” (“Derick”). The dissent
characterizes that article
-- 1 of 1 --
